drugset / Trial / NCT02429258

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

NCT02429258

Phase 4 Completed 226 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindTreatment

Summary

Effect of Dapagliflozin on 24-hour Blood Glucose in Type 2 Diabetes Patients Inadequately Controlled With Either Metformin Or Insulin

Timeline

Start
2015-05
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Forxiga Unknown 10 mg
Background Insulin Protein / enzyme biologic 30 iu
Background Metformin Small molecule 1500 mg